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Ca2+ elevations are fundamental to cardiac physi-
ology-stimulating contraction and regulating the
gene transcription that underlies hypertrophy. How
Ca2+ specifically controls gene transcription on the
background of the rhythmic Ca2+ increases required
for contraction is not fully understood. Here we iden-
tify a hypertrophy-signaling module in cardiac myo-
cytes that explains how Ca2+ discretely regulates
myocyte hypertrophy and contraction. We show
that endothelin-1 (ET-1) stimulates InsP3-induced
Ca2+ release (IICR) fromperinuclear InsP3Rs, causing
an elevation in nuclear Ca2+. Significantly, we show
that IICR, but not global Ca2+ elevations associated
with myocyte contraction, couple to the calcineurin
(CnA)/NFAT pathway to induce hypertrophy. More-
over, we found that activation of the CnA/NFAT
pathway and hypertrophy by isoproterenol and
BayK8644, which enhance global Ca2+ fluxes, was
also dependent on IICR and nuclear Ca2+ elevations.
The activation of IICR by these activity-enhancing
mediators was explained by their ability to stimulate
secretion of autocrine/paracrine ET-1.
INTRODUCTION
The heart is an extremely plastic organ that modifies its output
to meet increased hemodynamic demands. Acutely, this is
achieved by increasing the rate and force of contraction. Pro-
longed requirements for increased cardiac output are met by
a compensated hypertrophic response, characterized by
increased cell size rather than number, which serves to increase
cardiac function (Lorell and Carabello, 2000; Dorn and Force,
2005). Although this compensated response provides for the
greater requirements of athletes or expectant mothers, under
certainpathological conditions, cardiachypertrophycanbecome472 Molecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Idecompensated, manifesting itself in decreased cardiac output
that can lead to death (Lorell and Carabello, 2000; Allender
et al., 2006).
Ca2+ has a fundamental role in the biology of cardiac myo-
cytes—stimulating their contraction during every heartbeat as
well as the transcription of genes involved in cardiac hypertrophy
(Frey et al., 2000; Bers, 2002; Molkentin, 2006). Many of the pro-
hypertrophic effects of Ca2+ are mediated through the EF-hand-
containing Ca2+ sensor protein calmodulin (CaM) (Obata et al.,
2005; Heineke and Molkentin, 2006). Ca2+/CaM, in turn, either
directly interacts with transcriptional modulators such as the
CaM-binding transcription activator (CAMTA) (Song et al.,
2006), or as for type 2 histone deacetylases (HDACs) and
NFAT (Molkentin et al., 1998; Zhang et al., 2002a), regulates their
activity via Ca2+-sensitive enzymes that include Ca2+/CaM
kinase II (CaMKII) and calcineurin (CnA), respectively (Frey
et al., 2000; Heineke and Molkentin, 2006). Despite identifying
these Ca2+ targets and their mechanisms of action, it remains
to be fully established how Ca2+ can act with such great speci-
ficity and fidelity to control transcription on the background noise
of the global Ca2+ signals associated with every heartbeat.
To achieve this specificity, it has been suggested that stress/
workload-induced changes in the frequency, shape, or ampli-
tude of excitation contraction coupling (ECC)-associated Ca2+
transients could encode information that would induce hypertro-
phic gene transcription (Berridge et al., 2003). Alternatively,
altered Ca2+ signals could act coincidently with other signaling
mediators, such as MAPK and PKB, which are also activated
under hypertrophic conditions (Heineke and Molkentin, 2006).
A further possibility that has gained recent support is that Ca2+
signals generated via mechanisms distinct from ECC control
hypertrophic gene transcription. For example, by Ca2+ entry
through TRPC cation channels on the plasmamembrane (Kuwa-
hara et al., 2006; Nakayama et al., 2006; Brenner andDolmetsch,
2007) or by Ca2+ signals arising from endoplasmic reticulum
(ER)/sarcoplasmic reticulum (SR) InsP3 receptor (InsP3R) Ca
2+
channels (Perez et al., 1997; Lipp et al., 2000; Wu et al., 2006;
Zima et al., 2007). The stimulation of InsP3-induced Ca
2+ release
(IICR) downstream of plasma membrane receptors, such as thenc.
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trophy, further supports the idea that IICR is a regulator of hyper-
trophic gene transcription (Mackenzie et al., 2002; Zima and
Blatter, 2004). Indeed, a recent study showed that IICR could
activate CaMK, causing export of an exogenously expressed
GFP-HDAC and induction of a synthetic myocyte enhancer
factor 2 (MEF2) reporter in cardiac myocytes (Wu et al., 2006).
These data were extrapolated to suggest that IICR was a regu-
lator of myocyte hypertrophy. As no bona fide markers of hyper-
trophy were assessed, further analysis of the role of IICR in this
process is required.
Here, we set out to test the hypothesis that IICR provides
a discrete signaling mechanism to control hypertrophic gene
transcription independently of the Ca2+ transients associated
with ECC. Since IICR has now been widely reported in cardiac
myocytes (Kockskamper et al., 2008), regulating both ECC and
stimulating arrhythmogenic Ca2+ signals, we also set out to
establish whether IICR represented a conserved signalingmech-
anism employed in the induction of hypertrophy. Specifically,
whether it is employed by diverse hypertrophic stimuli and not
solely by hypertrophic agents that engage phospholipase C
(PLC)-coupled plasma membrane receptors. To these ends, we
examined the distinct roles of InsP3-stimulated Ca
2+ elevations
versus those arising due to ECC in the induction of hypertrophy.
We also investigated under what conditions IICR is employed to
induce hypertrophy, and the mechanism(s) by which IICR can
engage the transcriptional machinery. Our results show that
InsP3-stimulated increase in nuclear Ca
2+ and its engagement
of the CnA/NFAT pathway is a requisite and conserved signal
for the induction of hypertrophy by both neurohumoral and
activity-inducing stimuli in cardiac myocytes. Moreover, we
show that activity-induced secretion of paracrine/autocrine en-
dothelin-1 (ET-1) serves to create a link between myocyte
activity/workload and the induction of cardiac hypertrophy.
RESULTS
ET-1 Promotes Hypertrophy in an IICR-Dependent
Manner
Application of ET-1 for 24 hr to cultures of spontaneously beating
neonatal rat ventricular myocytes (NRVMs) induced a character-
istic hypertrophic effect (Figure 1A) as determined using
a number of well-characterized hallmarks. A principal marker
of hypertrophy used in this study, which has been extensively
validated in a number of different hypertrophy models, was atrial
natriuretic factor (ANF) (Shubeita et al., 1990; Aronow et al.,
2001). Cell surface area measurements were also used as an
obvious physical characteristic of hypertrophy. ANF expression
was quantitated by counting ANF immunoreactivemyocytes and
by quantitative real-time PCR (Figure 1A). a-actinin staining also
showed increased organization following ET-1 stimulation.
ET-1 promotes both IICR andmodulates Ca2+ transients asso-
ciated with ECC (Figure 1B) (Wu et al., 2006; Kockskamper et al.,
2008). Here we investigated the discrete contributions of IICR
and the Ca2+ transients associated with ECC to the prohypertro-
phic action of ET-1 (Figure 1B). Ca2+ imaging of NRVMs revealed
spontaneous Ca2+ transients that were significantly increased in
frequency following ET-1 application (Figure 1C). This chrono-Motropic action of ET-1 was not dependent upon InsP3 signaling,
since it was unaffected by expression of the type 1 InsP3
50-phosphatase, which metabolizes InsP3 to InsP2 (Figure 1C),
or application of the InsP3R antagonist 2-APB (Mackenzie
et al., 2002) (data not shown). In cells in which ECC was blocked
with nifedipine and mibefradil, antagonists of L-type and T-type
channels, respectively (‘‘ECC blocked’’) (Escobar et al., 2004),
ET-1 induced an elevation of intracellular Ca2+ that was sensitive
to expression of InsP3 5
0-phosphatase or 2-APB (Figure 1D and
data not shown). In summary, these data show that ET-1
promotes IICR and increases the frequency of ECC-associated
Ca2+ transients, although the latter effect is independent of IICR.
We next investigated whether inhibition of IICR affected ET-
1-stimulated hypertrophy. Intriguingly, inhibition of IICR with
InsP3 5
0-phosphatase or 2-APB abrogated the hypertrophic
response (Figures 1E and Figure S1 [available online]).
To assess whether hypertrophic remodeling was induced by
coincident ET-1-stimulated IICR and enhanced ECC, and to
determine whether IICR was necessary for hypertrophic remod-
eling, the effect of ET-1 wasmeasured inmyocytes in which ECC
was blocked. Under these conditions, despite the absence of
ECC-associated global Ca2+ transients, ET-1 retained its ability
to induce hypertrophy. Moreover, hypertrophy was again sensi-
tive to InsP3 5
0-phosphatase expression (Figure 1F). 2-APB
application also significantly reduced the ET-1-stimulated
increase in the percentage of ANF-positive NRVMs under
ECC-blocked conditions from 56.80% ± 3.77% to 43.79% ±
2.84% (p < 0.007). Together, these data indicate that ET-1 stim-
ulated hypertrophy is dependent upon IICR but not ECC.
ET-1 and InsP3 Ester Stimulate Increases
in Nuclear Ca2+
The sensitivity of ET-1-stimulated hypertrophy, but not chrono-
tropy, to inhibition of InsP3 signaling may appear discordant. To
rationalize these findings, we hypothesized that ET-1 was
promoting IICR in a microdomain that was spatially distinct
from the Ca2+ changes that were occurring during ECC, and that
this Ca2+ signal was insufficient to modify ECC but sufficient to
drive hypertrophic gene transcription. The confocal imaging
data in Figure 2A indicated that, during ECC, Ca2+ levels
increased throughout the cell, whereas under conditions where
ECC was blocked, ET-1 and cell-permeant InsP3 ester both
promoted Ca2+ increases that were constrained to the nucleus
(Figure 2A). The InsP3-dependent Ca
2+ increases correlated
with thesubcellular localizationof type2 InsP3Rs (InsP3R2),which
were enriched in the perinuclear region of the cardiac myocytes,
thus providing amechanism for the generation of localized InsP3-
signaling events (Figure 2B). The restricteddistribution of InsP3Rs
contrasts with that of type 2 RyRs (RyR2), which were expressed
throughout the cell, raising the possibility that InsP3Rs have
a specialized function in cardiac myocytes (Figure 2B).
The requirement for nuclear Ca2+ signals for ET-1-stimulated
ANF expression was next probed. To this end, nuclear Ca2+
was specifically buffered using a nuclear-targeted, red fluores-
cent protein (mRFP)-tagged form of the neuronal Ca2+ binding
protein calbindin (CB-NLS). Significantly, CB-NLS expression
abrogated ET-1-induced ANF expression in ECC-blocked myo-
cytes, as well as in myocytes that were spontaneously activelecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Inc. 473
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Figure 1. IICR Is Required for ET-1-Stimulated Hyper-
trophic Remodeling
(A) (Ai) Confocal images of neonatal myocytes treated ± ET-1
(100 nM; 24 hr) and then immunostained with antibodies to
ANF (red) and a-actinin (green). Nuclei are indicated by the
blue DAPI staining. White arrows indicate perinuclear rings of
ANF. Scale bar represents 50 mm. (Aii) Quantitation of ANF-
expressing NRVMs, ANF mRNA abundance, and cell surface
area following 24 hr exposure to ET-1.
(B) Schematic of the Ca2+ pathways activated by ET-1 in
cardiac myocytes and interventions imposed to inhibit ECC
(+Nif/Mib indicates nifedipine and mibefradil application) and
IICR (InsP3 5
0-Phos). VOC is an abbreviation of voltage-
operated channel.
(C) Effect of InsP3-5
0-phosphatase expression upon ET-
1-stimulated changes in Ca2+ signals in NRVMs. (Ci) Ca2+
recording from a spontaneously beating NRVM stimulated
with ET-1 (100 nM). (Cii) Fold changes in amplitude and
frequency of the Ca2+ transients in GFP- and InsP3 5
0-phos-
phatase-expressing NRVMs following ET-1 stimulation.
(D) Effect of InsP3 5
0-phosphatase expression upon ET-1-stim-
ulated Ca2+ changes in NRVMs in which ECCwas blocked. (Di)
Ca2+ recording in NRVM under the conditions indicated. (Dii)
Assessment of the effect of InsP3 5-phosphatase expression
upon ET-1-stimulated Ca2+ increases shown in (Di).
(E) Quantitation of hypertrophic remodeling in spontaneously
active NRVMs exposed to the conditions shown. Histograms
describe the percentage of ANF-positive myocytes (Ei), ANF
mRNA abundance (Eii), and cell surface area (Eiii).
(F) Quantitation of the effect of InsP3 5
0-phosphatase expres-
sion upon ET-1-stimulated hypertrophic remodeling in NRVMs
in which ECC was blocked. The percentage of ANF-express-
ing myocytes (Fi), ANFmRNA abundance (Fii), and cell surface
area (Fiii) are shown. Experiments were performed on
a minimum of three occasions. Data are presented as mean ±
SEM. Asterisk indicates statistical significance at p < 0.05. NS,
not significant.(Figures 2C and 2D). As the expression of CB-NLS only inhibited
increases in nuclear Ca2+, even in spontaneously beating myo-
cytes experiencing large cytosolic Ca2+ fluxes (Figure S2), these
data indicated that elevations in nuclear Ca2+ were required for
the induction of ANF expression by ET-1.
Since the CnA/NFAT pathway has been shown to mediate the
gene transcription required for pathological hypertrophy (Wilkins
et al., 2004), we next tested whether it was activated by IICR and
was involved in IICR-induced ANF expression. To this end, CnA
was inhibited with cyclosporin A (CsA), and NFAT activation by
CnA was prevented using a cell-permeant VIVIT peptide (Ara-
mburu et al., 1999). Both treatments significantly reduced ET-
1-stimulated ANF expression in cells in which ECC was blocked
(Figure 3A). The activity of an NFAT-luciferase reporter was also
induced by ET-1 stimulation in ECC-blocked cells (2.2 ± 0.46-
fold increase from control; p < 0.05, n = 4). Having shown that
ET-1-stimulated ANF expression was CnA/NFAT-dependent
under conditions where ECC was absent (only ET-1-stimulated
IICR), we next tested whether IICR was sufficient for nuclear474 Molecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Itranslocation of NFAT. ET-1 stimulated the nuclear accumulation
of GFP-tagged NFAT-C1 in an InsP3 5
0-phosphatase-sensitive
manner (Figure 3B). Moreover, even in myocytes experiencing
ECC-associated global Ca2+ signals, ET-1-stimulated NFAT-
C1 nuclear translocation was sensitive to InsP3 5
0-phosphatase
expression (Figure 3B).
The important role of ET-1-stimulated IICR in the nucleus for
the activation of the CnA/NFAT pathway was further substanti-
ated by the decrease in ET-1-induced ANF expression observed
inmyocytes treatedwith a cell-permeant peptide inhibitor of CnA
nuclear translocation (Hallhuber et al., 2006) (Figure 3C).
Together, these data show that ET-1 induces hypertrophy by
causing InsP3-stimulated increases in nuclear Ca
2+, which acti-
vates the CnA/NFAT pathway.
IICR Is an Obligate Signal for Workload-Induced
Hypertrophy
The role of InsP3 signaling in hypertrophy induced by the
b-adrenergic agonist isoproterenol or the L-type channel agonistnc.
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IICR Activates NFAT to Induce HypertrophyBayK8644 was next investigated. Both of these agents act to
increase Ca2+ cycling, thereby mimicking increased workload
(Figures 4A and 4B). BayK8644 was used, as it acts solely to
enhance Ca2+ fluxes through the L-type channel and could
therefore control for Ca2+-independent actions of b adrenergic
stimulation. The potent modification of Ca2+ cycling by these
0 4.5 9
0.0
12.5
25.0
Time (sec)
F/
F 0
0 4.5 9
0
5
10
Time (sec)
0 4.5 9
0.0
7.5
15.0
Time (sec)
F/
F 0
0 4.5 9
0
6
12
Time (sec)
ANF +ve cells
0
30
60
%
ANF +ve Cells
0
30
60
%
RyR 2 InsP3R2 Overlay
Beating
[C
a2
+ ] i
ECC Blocked
(+Nif/Mib)
+ET-1
ECC Blocked
(+ Nif/Mib)
+ InsP3-ester
Beating
Cytosol
Nucleus
Cytosol
C
N
C
B
Ai Aii
NucleusCytosol
N N
C D
ET-1: + +
+ Nif/Mib
CB-NLS: + +
+ +
+ +
* *
CB-NLS
mRFP Overlay
Overlay
Figure 2. ET-1-Stimulated InsP3-Dependent Elevations in Nuclear
Ca2+ that Are Required for Its Induction of ANF Expression
(A) ET-1 and InsP3-ester induce nuclear-specific Ca
2+ signals in NRVMs.
(Ai and Aii) The upper panels show surface plots of fluo-4 intensity in either
spontaneously beating or ECC-blocked myocytes treated ± ET-1 or InsP3-
ester. Images of two myocytes are shown in each case. N indicates the
position of the nucleus. The middle panels show the corresponding time
projections of intensity from a 10 pixel wide line drawn across the cell through
the center of the nucleus. The positions of the nucleus (N) and cytosol (C) are
shown. The lower panel shows plots of fluo-4 fluorescence taken from the
dashed lines shown in the middle panel.
(B) Confocal images of NRVMs labeled with antibodies directed against the
type 2 RyR (red) and the InsP3R2 (green). Scale bar represents 10 mm.
(C) Confocal images of NRVMs transfected with mRFP or mRFP-CB-NLS
(CB-NLS; both in red). Myocytes are counterstained with an antibody against
a-actinin and with DAPI (cytosol and nuclei stained; both in blue). Scale bar
represents 20 mm.
(D) Quantitation of ET-1-stimulated ANF expression in myocytes expressing
either mRFP or CB-NLS. Data are presented as mean ± SEM. Asterisk indi-
cates statistical significance at p < 0.05.Molagents was insensitive to InsP3 5
0-phosphatase expression,
indicating that their enhancement of ECC was independent
of the Gaq-InsP3-signaling pathway (Figure 4C). However,
BayK8644- and isoproterenol-stimulated increases in ANF
expression and cell size were inhibited by expression of InsP3
50-phosphatase (Figure 4D). Moreover, BayK8644-stimulated
NFAT nuclear accumulation was also significantly reduced by
InsP3 5
0-phosphatase expression (10.18 ± 0.53-fold increase
over controls in BayK8644-treated cells versus 6.723 ± 1.03
in InsP3 5
0-phosphatase-expressing BayK8644-treated cells,
n = 9; p < 0.05). As the BayK8644- and isoproterenol-mediated
enhancement of ECC was not affected by InsP3 5
0-phosphatase
expression (Figures 4Ci and 4Cii), these data indicated that ANF
expression and NFAT nuclear translocation were not directly
regulated by ECC-associated Ca2+ oscillations.
Autocrine/Paracrine Signaling Involving ET-1 Drives
IICR and Hypertrophy
Since ET-1 is known to signal in a paracrine/autocrine manner in
cardiac myocytes (Ergul et al., 2000; Motte et al., 2003), we next
investigated whether this contributed to the InsP3 dependence
A
B
C
5'-P5'-P
Figure 3. ET-1-Stimulated IICR Engages the CnA/NFAT Pathway
(A) Quantitation of ANF expression in ECC-blocked NRVMs stimulated with
ET-1 and treated with either CsA (500 nM, 30 min pretreatment; left panel) or
cell-permeant VIVIT (2 mM, 30 min pretreatment; right panel).
(B) Effect of InsP3 5
0-phosphatase on ET-1-stimulated increases in NFAT
nuclear accumulation in ECC-blocked and spontaneously active myocytes.
Fold changes in the percentage of myocytes expressing GFP-NFATC1 in the
nucleus are shown.
(C) Quantitation of ANF immunoreactive myocytes following ET-1 stimulation
and application of a cell-permeant peptide (pep; 1 mM, 4 hr pretreatment)
inhibitor of CnA nuclear import. Data are presented as mean ± SEM. Asterisk
indicates statistical significance at p < 0.05.ecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Inc. 475
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IICR Activates NFAT to Induce Hypertrophyof BayK8644- and isoproterenol-induced hypertrophy (Fig-
ure 5A). Application of the selective ETAR antagonist BQ123
(Russell and Molenaar, 2000) completely abolished the prohy-
pertrophic effects of both isoproterenol and BayK8644 (Fig-
ure 5B). The ET-1-stimulated enhancement of ECC-associated
Ca2+ transients and IICR were both inhibited by BQ123, indi-
cating that the effects of ET-1 on Ca2+ were mediated by ETAR
and that BQ123 was an effective antagonist of ET-1 in these
cells (Figure S2). BayK8644-induced enhancement of ECC was
unaffected by BQ123, indicating that the effect of BQ123 was
specific to the ET-1 signaling cassette (Figure S2).
To further test the paracrine/autocrine action of ET-1, inhibitors
of its processing and secretion were employed (Figure 5A).
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Figure 4. Enhanced ECC Induces Hypertrophic Remodeling in an
InsP3-Dependent Manner
(A) Experimental manipulations used to increase myocyte activity/ECC.
(B) Ca2+ recordings in spontaneously beating NRVMs stimulated with isopro-
terenol (Iso; [Bi]) or BayK8644 (BK; [Bii]).
(C) Effect of InsP3 5
0-phosphatase expression upon isoproterenol (Ci)- or
BayK8644 (Cii)-induced changes in amplitude and frequency of Ca2+ signals
in spontaneously beating NRVMs.
(D) Quantitation of hypertrophic remodeling in NRVMs exposed to the condi-
tions shown. Histograms show the percentage of ANF-positive myocytes,
ANF mRNA abundance, and cell surface area. 50-P indicates expression of
InsP3 5
0-phosphatase. GFP was expressed in controls. Data are presented
as mean ± SEM. Asterisk indicates statistical significance at p < 0.05.476 Molecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier IPhosphoramidon, which inhibits ET-1 processing by endothe-
lin-converting enzyme, significantly suppressed the prohypertro-
phic actions of BayK8644 and isoproterenol (Figure 5B). The
specificity and lack of toxicity of phosphoramidonwere validated
by the induction of ANF expression in phosphoramidon-treated
cells by exogenous ET-1 (Figure 5B). Inhibition of secretion with
primaquine (Hiebsch et al., 1991) also abrogated BayK8644-
induced hypertrophy (Figure 5C). This inhibitory effect of prima-
quine upon BayK8644-induced ANF expression was rescued
by application of exogenous ET-1, indicating that it was affecting
ET-1 secretion, not ET-1 signaling (Figure 5C). Moreover, prima-
quine did not affect spontaneous Ca2+ transients (data not
shown). Further evidence in favor of an autocrine/paracrine
A
B C
D E
Figure 5. An Autocrine/Paracrine Pathway Involving Secretion of
ET-1 Underlies Induction of ANF Expression by Enhanced ECC
(A) Schematic of the pathways that link Ca2+ signals and ET-1. The agents
used to intervene in ET-1 processing and signaling and their sites of action
are also shown.
(B) Histogram showing the effect of BQ123 (B) and phosphoramidon (P) upon
the percentage of ANF-expressing myocytes induced by BayK8644 (BK),
isoproterenol (Iso), or ET-1 (ET).
(C) Histogram showing the effect of primaquine (Pq) upon BayK8644-
stimulated increase in the percentage of ANF-expressing cells. The effects
of ET-1 (E) upon control and primaquine-treated BayK8644-stimulated myo-
cytes are also shown.
(D) Quantitation of ET-1 levels in the media overlying cultures of NRVMs. The
fold change between control and test conditions is presented.
(E) Histogram showing the effect of BayK8644 ± BQ123 upon the percentage
of myocytes with nuclear NFAT. Data are presented as mean ± SEM. Asterisk
indicates statistical significance at p < 0.05.nc.
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IICR Activates NFAT to Induce Hypertrophyaction of ET-1 was provided by the significant increase in ET-1
detected in medium overlying the neonatal myocytes following
application of BayK8644 for 24 hr (Figure 5D). The BayK8644-
stimulated increase in ET-1 was prevented by coapplication of
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Figure 6. Autocrine/Paracrine ET-1 and InsP3 Signaling Are
Required for Induction of ANF Expression in ARVMs
(A) Confocal images of ARVMs captured following 24 hr culture in the agents
indicated. ANF is shown in red, a-actinin is shown in green, and nuclei are indi-
cated by the blue DAPI staining. Scale bar represents 20 mm.
(B and C) Quantitation of the effects of 2-APB (B) or InsP3 5
0-phosphatase
expression (C) upon the percentage of myocytes expressing ANF following
24 hr exposure to ET-1, BayK8644, or isoproterenol. Controls in the 50-phos-
phatase experiments express GFP.
(D) Effect of BQ123 upon BayK8644-induced increases in the percentage of
ANF-expressing myocytes.
(E) Confocal image of an ARVM immunostained with antibodies against RyR2
(red) and InsP3R2 (green). Nuclei are indicated by the blue DAPI staining. Scale
bar represents 10 mm.
(F) Confocal imaging of Ca2+ in the cytosol and nucleus of paced ARVMs. (Fi)
Normalized traces illustrating nuclear and cytosolic Ca2+ prior to ET-1 applica-
tion and 50 s after ET-1 application. (Fii) Summarized nuclear:cytosolic ratio of
F/F0 normalized to prestimulation conditions. Data are presented as mean ±
SEM. Asterisk indicates statistical significance at p < 0.05.Mophosphoramidon (Figure 5D). BQ123 application also signifi-
cantly reduced the nuclear accumulation of NFAT in BayK8644-
stimulated cells (Figure 5E). Together, these data are consistent
with a model in which myocyte activity promotes ET-1 secretion,
which then acts in an autocrine/paracrine manner and signals via
IICR and CnA/NFAT to induce ANF expression.
ET-1-Stimulated IICR Underlies Hypertrophic
Remodeling in Myocytes Isolated from Adult Rats
The role of IICR and autocrine/paracrine ET-1 signaling in
hypertrophic signaling was also examined in adult rat ventricular
myocytes (ARVMs). As observed in NRVMs, ET-1, BayK8644,
and isoproterenol also potently induced ANF expression in
ARVMs (Figures 6A–6C). Moreover, the effect of these agents
on the induction of ANF expression was significantly reduced
by abrogation of IICR by InsP3 5
0-phosphatase expression or
2-APB treatment. Consistent with the data in NRVMs,
BayK8644-induced ANF expression in ARVMs was also BQ123
sensitive (Figure 6D). Mirroring the data in NRVMs, type 2
InsP3Rs were in greatest abundance in a region that surrounded
and spanned between the two nuclei (Figure 6E). As we have
previously shown (Mackenzie et al., 2002), some InsP3Rs were
also present near the sarcolemma and on the striations that indi-
cate the sarcoplasmic reticulum. The RyRs, in contrast, were
distributed in a striated pattern throughout the cytoplasm.
Confocal Ca2+ imaging of paced ARVMs revealed an
ET-1-stimulated increase in nuclear Ca2+, relative to cytosolic
Ca2+ (Figure 6F). The ET-1-induced increase in nuclear to cyto-
solic Ca2+ ratio was 2-APB sensitive and therefore likely due to
ET-1-mediated activation of nuclear InsP3Rs.
DISCUSSION
The data presented in this study provide insights into the mech-
anisms that allow discrimination between Ca2+ signals that
induce contraction and those that stimulate hypertrophy in
cardiac myocytes. Specifically, they shed light on the funda-
mental role of and differences between neurohormonally
stimulated IICR and ECC-associated Ca2+ signals, and their
respective Ca2+ sources, in regulating cardiac hypertrophy.
Together, our data show that IICR and its activation of the
CnA/NFAT pathway is a signaling nexus in the transduction
mechanism of different hypertrophic stimuli (Figure 7).
Many lines of evidence have implicated Ca2+ in the regulation
of cardiac hypertrophy (Heineke and Molkentin, 2006). Indeed,
as Ca2+ signaling is acutely modified to regulate cardiac output,
a possible role for Ca2+ in regulating hypertrophic growth is easy
to understand: more work, more activity, more heart (Bers,
2002). Despite significant research, the precise mechanism by
which hypertrophy is regulated by Ca2+ remains widely debated
(Molkentin, 2006).
Here we establish a model that places IICR as a common and
requisite signaling module for the induction of hypertrophy by
stimuli that directly activate InsP3 production, as well as those
that increase myocyte activity through the enhancement of
ECC (Figure 7). Using a number of approaches to manipulate
InsP3 signaling in intact cells, we determined that hypertrophy
is induced in an IICR-dependent manner by ET-1, the b-agonistlecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Inc. 477
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Although these agonists all elicited a chronotropic effect, this
did not contribute to their prohypertrophic action. Moreover,
ET-1-induced IICR promoted hypertrophy in the absence of
ECC-associated Ca2+ transients. Although ET-1, acting via its
Gaq-coupled receptor, is capable of promoting IICR in cardiac
myocytes (Mackenzie et al., 2002; Zima and Blatter, 2004), it
was not clear how isoproterenol and BayK8644 could engage
IICR. These agents were shown to elicit IICR by promoting ET-
1 secretion, which then acted in an autocrine/paracrine manner
to induce hypertrophy (Figure 7). Interestingly, in a recent study,
HDAC5 nuclear export (which was used as a surrogate for hyper-
trophy) was shown to be induced by IICR but not ECC-mediated
Ca2+ fluxes generated by electrical pacing (Wu et al., 2006). From
these data, it was concluded that increased activity could not
induce hypertrophy. However, as described above, measuring
ANF expression and myocyte size in both neonatal and adult
myocytes asmore bona fide indices of hypertrophy, we revealed
that hypertrophy was sensitive to increased activity. Due to the
extended time course of our experiments (compared to the Wu
et al. study), myocytes had sufficient time to elicit an autocrine/
paracrine response involving ET-1, thereby allowing increased
Ca2+ cycling to drive hypertrophy by recruiting IICR. Our conclu-
sions that ET-1-stimulated IICR is a conserved signaling module
employed in regulating hypertrophy is also supported by the lack
of hypertrophy in mice in which components of the ET system
have been genetically ablated (Wettschureck et al., 2001; Shohet
Hypertrophy
Figure 7. Model Depicting theMechanism bywhich ET-1-Stimulated
IICR Coordinates Hypertrophic Signaling
Engagement of ET receptors stimulates an increase in intracellular InsP3,
which mobilizes Ca2+ from a perinuclear SR/ER Ca2+ store, causing Ca2+ to
increase in the nucleus. IICR engages the CnA/NFAT signaling pathway to
induce hypertrophic remodeling. The effect of IICR is in part mediated by
InsP3-stimulated increases in nuclear Ca
2+ sustaining NFAT nuclear localiza-
tion by maintaining an interaction between CnA and NFAT. This ET-1/InsP3/
Ca2+/CnA/NFAT pathway is also engaged following increases in myocyte
work rate brought about through b-adrenergic receptor engagement or
enhanced Ca2+ entry through L-type voltage-operated channels. This
enhanced Ca2+ cycling promotes ET-1 secretion, which then acts on its
cognate receptor to activate the prohypertrophic pathway described above.478 Molecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Iet al., 2004). It is also interesting to note that ET-1 secretion and
biosynthesis, as well as ETAR levels, are upregulated in a number
of cardiac disease models (Zolk et al., 2002; Motte et al., 2003).
The specific prohypertrophic action of IICR prompted us to
investigate the mechanism that allows prohypertrophic signal
transducers to discriminate between IICR and enhanced ECC-
associated Ca2+ transients downstream of ET-1 stimulation.
We showed that InsP3Rs are localized around the nucleus, and
in response to cellular stimulation with a physiological agonist
or InsP3 they release Ca
2+ into a microdomain surrounding or
within the nucleus, causing an increase in nuclear Ca2+. These
findings are consistent with a small but growing body of
evidence demonstrating that IICR can occur in the nuclear region
of primary cardiac myocytes (Wu et al., 2006; Heidrich et al.,
2008; Kockskamper et al., 2008). Significantly, we were also
able to demonstrate in cells expressing a nuclear-localized
Ca2+ buffer that this elevation in nuclear Ca2+ elicited by InsP3
was required for the induction of hypertrophy by ET-1.Moreover,
buffering nuclear Ca2+ prevented ET-1-stimulated ANF expres-
sion not only in myocytes in which IICR was the only Ca2+ signal
but also in spontaneously active myocytes experiencing global
ECC-associated Ca2+ fluxes. Together, these observations
lead us to suggest that Ca2+ signals emanating from InsP3Rs
occur in a privileged nuclear microdomain appropriate to drive
transcription, whereas Ca2+ signals that arise as a result of
ECC do not. These findings are analogous to that observed in
neurons and skeletal muscle cells where nuclear Ca2+ changes
have been proposed to specifically regulate gene transcription
(Hardingham et al., 1997; Cardenas et al., 2005).
In this manuscript, we identify the CnA/NFAT pathway as a key
mechanism by which the requisite InsP3-stimulated increase in
nuclear Ca2+ couples to the transcriptional machinery to induce
hypertrophy. As the CnA/NFAT pathway is an established medi-
ator of pathological hypertrophy, these findings are particularly
important and uncover a signaling link to NFAT activation (Mol-
kentin et al., 1998; Wilkins et al., 2004). More significantly, as
a result of buffering nuclear Ca2+ or inhibiting IICR, we were
able to show that the enhanced ECC-associated global Ca2+
transients generated following stimulation with hypertrophic
agonists, including ET-1, isoproterenol, and BayK8644, do not
provide the Ca2+ signals that cause activation of the CnA/
NFAT pathway. Rather, these stimuli, either directly, as for ET-1,
or indirectly via secretion of autocrine/paracrine ET-1, as for
isoproterenol and BayK8644, promote IICR, which then through
an elevation in nuclear Ca2+ activates the CnA/NFAT pathway. It
is important to note that our conclusions for this role of the CnA/
NFAT pathway are based on analysis of the role of the CnA/NFAT
pathway on the ET-1-stimulated induction of expression of a
bona fide hypertrophy-associated protein (ANF) (Aronow et al.,
2001), as well on the effect of IICR and nuclear Ca2+ transients
on the activation of an NFAT-luciferase reporter and NFAT trans-
location. Together, these findings showing that the NFAT
pathway is activated in an IICR-dependent manner by different
hypertrophic stimuli provide insight into the mechanisms by
which these diverse stimuli can utilize Ca2+ to induce hyper-
trophy. The employment of IICR to induce the CnA/NFAT
pathway to promote hypertrophic gene transcription is an attrac-
tive model, as due to its kinetics of activation and deactivation,nc.
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NFAT constitutively nuclear and active (Tomida et al., 2003).
The requirement for additional Ca2+ signals provided by IICR
would endow greater specificity and room for modulation.
Although previous reports have suggested that NFAT is a simple
integrator of the frequency of Ca2+ oscillations (Colella et al.,
2008), our data would suggest a more complex scenario
requiring autocrine/paracrine ET-1 signaling and IICR to maxi-
mally activate NFAT-mediated transcription. Indeed, although
inhibition of IICR or ETAR completely inhibited BayK8644- or
ET-1-stimulated ANF expression, these maneuvers did not fully
prevent BayK8644-stimulated nuclear accumulation of NFAT.
Our data showing the importance of nuclear Ca2+ in the
regulation of the CnA/NFAT pathway are consistent with the
reports in T lymphocytes that sustained elevation in Ca2+ is
required for optimal induction of gene transcription by NFAT
(Feske et al., 2000). Although sustained NFAT activity could be
mediated by prolonged elevations in cytosolic Ca2+ and CnA-
mediated dephosphorylation of NFAT in the cytosol, CnA also
plays a role in the nucleus. There, CnA can sustain NFAT activity
via a noncatalytic mechanism by associating with NFAT,
occluding its nuclear export sequence and thereby maintaining
its nuclear localization (Zhu and McKeon, 1999). Here, we find
that nuclear CnA as well as elevated nuclear Ca2+ is required
for IICR-induced ANF expression. As we also find that IICR-stim-
ulated nuclear Ca2+ elevations increase nuclear NFAT, our data
suggest that IICR engages CnA in the nucleus to enhance
NFAT activation and hypertrophic gene transcription. Although
our data show that InsP3-stimuated increases in nuclear Ca
2+
are required for induction of hypertrophy and NFAT accumula-
tion in the nucleus, IICR may also elicit some of its actions in
the perinuclear region of the cytosol. Interestingly, ET-1 stimu-
lates GFP-CnA nuclear translocation in blocked cells (data not
shown). Specificity in IICR signaling in this region as well as in
the nucleusmay be imparted through the reported physical inter-
action between CnA and InsP3Rs (Cameron et al., 1995).
Through its phosphorylation of HDACs, CaMKII has also been
shown to be an important regulator of hypertrophic gene tran-
scription (Zhang et al., 2002a; Zhang et al., 2002b). Indeed,
IICR has been shown to activate nuclear-localized delta(b) iso-
form of CaMKII, inducing HDAC5 nuclear export and activation
of a MEF2-luciferase reporter (Wu et al., 2006). As discussed
earlier, whether IICR induces the expression of hypertrophy via
this CaMK/HDAC pathway requires further investigation. We
did not, however, detect sensitivity of ANF expression to
CaMK inhibition (data not shown). CaMKII-dependent hyper-
trophy has been shown to be induced following isoproterenol
treatment, although the requirement for IICR for hypertrophy
on this background was not determined (Morisco et al., 2000).
As hypertrophy is manifest through synergistic interactions
between multiple signaling pathways (Heineke and Molkentin,
2006), it is likely that Ca2+ simultaneously coordinates numerous
inputs during the induction of hypertrophy. Moreover, although
we report that IICR is required for the induction of hypertrophy,
IICR is unlikely to operate by itself in the induction of hypertro-
phic gene transcription. Concomitantly with induction of IICR,
ET-1 receptor engagement would also lead to the activation,
among others, of PKD, PKC, and MAPK signaling pathwaysMo(Dorn and Force, 2005; Sugden and Clerk, 2005). These signals
would likely synergize with IICR to regulate gene transcription.
The array of pathways involved in hypertrophy may also allow
for redundancy; for example, under certain circumstances the
requirement for IICR may be circumvented in the induction of
hypertrophy.
To summarize, our data show that a signalingmodule involving
ET-1-stimulated IICR and activation of NFAT plays a requisite
and coordinating role in the induction of hypertrophic gene
expression under conditions that increase cardiac work rate.
The relevance of these findings to disease is immediately
apparent. Specifically, the NFAT pathway is a well-defined and
important regulator of pathological hypertrophy (Wilkins et al.,
2004). Moreover, InsP3R expression (Go et al., 1995) and circu-
lating ET-1 are increased during heart failure. Together,
increases in the expression and/or activity of these signaling
mediators could synergize to exacerbate the disease state. In
addition, it is possible that IICR-associated arrhythmic events
(Kockskamper et al., 2008) would also be increased, thereby
compounding the severity of disease. These profound effects
of ET-1 on the heart suggest that this pathway would be an
attractive target for pharmacological intervention. Thus far, the
responses of both animal and humans to ET receptor inhibitors
have been inconsistent, possibly due to disease state or history
(Ito et al., 1994). The antihypertrophic effect of deleting the
prepro-ET-1 gene in mice (Shohet et al., 2004) would suggest,
however, that targeting the ET system in a cardiac-specific
manner could prove beneficial.
EXPERIMENTAL PROCEDURES
Materials
Cell-permeant VIVIT peptide and porcine ET-1 were from Calbiochem. Chem-
icals were from Sigma or BDH, unless stated otherwise.
Preparation and Culture of Cardiac Myocytes
NRVMs were prepared and cultured as previously described with minor modi-
fications (Iwaki et al., 1990) (see Supplemental Data). Following isolation and
preplating to remove contaminating fibroblasts, myocytes were seeded at
0.2 3 106 cells/cm2 in plating medium (4 parts DMEM with 4.5 g/l D-Glucose,
585 mg/l L-glutamine, 110 mg/l sodium pyruvate (Invitrogen) and 1 part M199,
supplemented with 10% donor horse serum, 5% fetal calf serum, 1 mM
sodium pyruvate, 1 mM MEM nonessential amino acids (Invitrogen), 1% anti-
biotic/antimycotic, and 3 mM cytosine b-D-arabinofuranoside (ara-C) on 1%
gelatin-coated dishes or laminin (25 mg/ml; Invitrogen)-coated coverslips.
Plating medium was replaced after 24 hr and left for a further 24 hr. Cells
were then starved for 24 hr in maintenance medium (plating medium without
serum and nonessential amino acids supplemented with 5.5 mg/ml transferrin,
5 ng/ml selenium). Myocyte cultures were >95% pure. Following starvation,
cells were cultured inmaintenancemedia for 24 hr, in the presence or absence
of agonists/antagonists.
ARVMs were prepared as previously described (Lipp et al., 2000). For
culture, myocytes were transferred into culture medium (M199 – HEPESmodi-
fication, containing 0.2% BSA, 1.3 mM L-glutamine, 2.5 mM pyruvic acid,
5 mM creatine, 2 mM L-carnitine, 5 mM taurine, 5.5 mg/ml selenium, 3 mM
ara-C and 1% antibiotic/antimycotic [Invitrogen]) and plated onto laminin-
coated coverslips (25 mg/ml). After 2 hr, cells were exposed to the experimental
manipulation and cultured for 20–24 hr in culture medium.
Generation of Nuclear Localized Calbindin
Expression vectors for nuclear-targeted (23 large T-antigen NLS) calbindin
NH2-terminally tagged with mRFP and for mRFP were prepared accordinglecular Cell 33, 472–482, February 27, 2009 ª2009 Elsevier Inc. 479
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B. Schwaller (Fribourg, SZ) andR. Tsien (UCSD), respectively. Details are given
in the Supplemental Data.
Real-Time Quantitative PCR
RNA was isolated frommyocytes using the QIAGEN RNAeasy mini kit (with on
column DNase treatment), according to the manufacturer’s protocol. Total
RNA (500 ng) was reverse transcribed with Superscript II reverse transcriptase
(Invitrogen). Quantitative real-time PCR (qPCR) was performed using an ABI
Prism 7700 Sequence Detection System using gene-specific primers that
spanned exon boundaries and SYBR Green. Relative expression values
were determined using the geNorm method (Vandesompele et al., 2002).
Further details are in the Supplemental Data.
Immunofluorescence
Cells on coverslips were washed twice in PBS and then fixed for 15 min at 4C
in PBS (pH 7.4) containing 2% paraformaldehyde (w/v) and 0.05% glutaralde-
hyde (v/v). Cells were then washed three times with PBS and permeabilized in
PBS containing 0.2% TRITON X-100 for 15 min. Autofluorescence was
quenched with 1 mg/ml NaBH4. Nonspecific protein binding sites were
blocked by incubation for 1 hr in PBS/0.1% TRITON X-100/goat serum
(5%, w/v) (blocking buffer). Primary antibodies—monoclonal anti-InsP3R2
(Sugiyama et al., 1994) (1:250), polyclonal anti-RyR2 (1:100; gift of V. Sorren-
tino, University of Sienna), monoclonal anti-cardiac actinin (1:500; Sigma),
and polyclonal anti-ANF (1:500; Peninsula Laboratories)—were diluted in
blocking buffer and incubated with the cells for a further 1 hr. Excess antibody
was removed by washing for 1 hr in PBS/0.1% TRITON X-100 (wash buffer).
Bound antibodies were detected using Alexa Fluor-conjugated secondary
antibodies (Invitrogen), which were diluted at 1:500 in wash buffer containing
0.2% goat serum and incubated with the cells for 1 hr. Excess secondary anti-
bodies were removed by washing for 1 hr in wash buffer. Coverslips were
mounted on slides using Vectashield ± DAPI. Cells were imaged using a Zeiss
LSM 510META configured on an inverted microscope equipped with 403,
1.3 n.a or 603, 1.4 n.a oil immersion objectives, or on an Olympus Fluoview
1000 equipped with 403, Plan apochromat 1.35 n.a. oil immersion objective.
Cell Size Measurements
Area measurements of confocal images of individual cells were determined
using Volocity software (Improvision). For each condition,R100 cells on four
or more coverslips (five fields of view per coverslip) from two or more prepara-
tions of cells were used.
Adenoviral Infection
Adenoviral vectors for GFP/cherry and GFP/cherry-tagged type 1 InsP3
50-phosphatase were prepared with standard procedures using the flp/frt
recombinase system (Microbix Biosystems Inc; see Supplemental Data for
details of construct generation). Adenovirus for GFP-NFAT-C1 and NFAT-
Luc were kind gifts of M. Schneider (University of Maryland) and J. Molkentin
(University of Cincinnati), respectively, and have been described elsewhere
(Liu et al., 2001; Wilkins et al., 2004). Viruses were purified using the Vivapure
AdenoPack 100 viral purification kit (Sartorius). Viral titer was determined by
OD or end-point dilution and used at a concentration that transduced greater
than 95% of cells. For infection, virus was added in a minimal volume of media
overlying the cells and incubated for 3 hr in the case of neonatal myocytes and
overnight for adult myocytes. Virus-containing media was then removed and
either replaced with media or media-containing agonist.
Transfection
Myocytes cultured in laminin-coated 16-well glass chamber slides were trans-
fected in serum-free media. For transfection, 0.8 mg DNA, 2 ml Nupherin
(BIOMOL), and 0.4 ml Lipofectamine LTX (Invitrogen) was used per well.
Ca2+ Imaging
Myocytes on glass coverslips were washed with imaging buffer (10 mM
HEPES [pH 7.35], 135 mM NaCl, 5.4 mM KCl, 2 mM MgCl2, 10 mM glucose,
1.5 mM CaCl2) and then loaded with 2 mM fura-2 AM diluted in imaging buffer.
Following 30 min incubation at 37C, cells were washed and incubated for480 Molecular Cell 33, 472–482, February 27, 2009 ª2009 Elseviera further 25 min at 37C to de-esterify the dye. The coverslips were then
mounted in an imaging chamber and transferred to the temperature-controlled
(37C) stage of a Nikon TE200 inverted microscope. Cells were imaged
through a 403, 1.3 n.a. S Fluor oil immersion phase objective with alternate
excitation at 340 and 380 nm. Light was filtered through a 400 nm long-pass
dichroic and a 460 nm long-pass emission filter. Images were captured using
a Hamamatsu Orca ER cooled CCD camera.
Confocal imaging of fluo-4-loaded myocytes was performed using an
Olympus FluoView 1000 attached to an Olympus IX81. The cells were illumi-
nated with the 488 nm line of an Argon/Krypton laser and imaged through
a 403, 1.3 n.a. UPlanFl oil immersion objective at 15.4 frames/s. For dye
loading, cells were incubated with 2 mM fluo-4-AM at 37C for 30 min followed
by de-esterification at 37C for a further 30 min. Cells were imaged in imaging
buffer as described above for fura-2 imaging, but containing 1 mM CaCl2 for
ARVMs. Images were analyzed off-line using ImageJ software (http://rsb.
info.nih.gov/ij/).
Assays of NFAT Activation
GFP-NFATC1 nuclear accumulation was quantitated 4 hr poststimulation with
ET-1. Cells were fixed and immunostained with a-actinin. Myocytes with GFP-
NFAT predominantly in the nucleus were classed as NFAT positive. NFAT-
driven luciferase activity was determined 24 hr poststimulation using the
Promega Luciferase Assay System.
ET-1 Enzyme Immunometric Assay
ET-1 was quantitated using an enzyme immunometric assay (EIA) kit (Assay
Designs). The culture medium (900 ml) was removed from myocytes cultured
in 6-well dishes (following 24 hr of treatment) and stored at20C. To achieve
detectable ET-1 levels, samples from multiple preparations were pooled and
then concentrated using Sep-Pak tC18 reversed-phase chromatography
cartridges (Waters). Samples were eluted in 250 ml 50% MeOH/5% formic
acid. Eluates were dried in a SpeedVac and resuspended in 220 ml of EIA assay
buffer by incubation in a sonnicator water bath. The EIA was carried out as per
the manufacturer’s protocol.
Statistical Analysis
Data are presented as mean ± SEM. Data were analyzed using a one-tailed
Student’s t test or using a one-way ANOVA and Tukey post hoc test and
were accepted as significant when p < 0.05.
SUPPLEMENTAL DATA
The Supplemental Data include Supplemental Experimental Procedures and
three figures and can be found with this article online at http://www.cell.
com/molecular-cell/supplemental/S1097-2765(09)00101-4.
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